Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing

Dora Szabó1, Julia Szentandrássy, Zsuzsa Juhász

  • 1Institute of Medical Microbiology, Semmelweis University, Budapest, H-1089, Nagyvárad tér 4., Hungary. szabdor@net.sote.hu

Abstract

Insights

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii strains producing carbapenemases were identified in Hungary. These resistant bacterial strains highlight the global spread of antimicrobial resistance and the need for patient screening.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa and Acinetobacter baumannii are significant nosocomial pathogens.
  • Increasing prevalence of multidrug-resistant strains due to acquired resistance mechanisms like extended-spectrum beta-lactamases (ESBLs) and metallo beta-lactamases (MBLs).

Observation:

  • A case of a Hungarian tourist hospitalized in Egypt and later transferred to Hungary.
  • Isolation of PER-1-producing P. aeruginosa, PER-1-producing A. baumannii, SHV-5-producing Klebsiella pneumoniae, and VIM-2-producing P. aeruginosa from patient samples.
  • Pulsed-field gel electrophoresis (PFGE) indicated that PER-1 and VIM-2 producing P. aeruginosa strains were of external origin.

Findings:

  • First report of PER-1-producing P. aeruginosa and PER-1-producing A. baumannii in Hungary.
  • Identification of multidrug-resistant strains with acquired resistance mechanisms in a traveler.

Implications:

  • Highlights the international spread of beta-lactamase-mediated resistance mechanisms.
  • Emphasizes the importance of rigorous screening and isolation protocols for patients arriving from different countries.
  • Underscores the global challenge posed by multidrug-resistant organisms (MDROs) in healthcare settings.